Back to Headlines
Entertainment
Apr 26, 2026
Analyzed by GPT OSS 120B

Heartsink Review – A Terminally‑Ill Doctor’s Struggle to Be a Patient

AI Summary
The Guardian’s review of Sean Turner’s new play *Heartsink* examines how the drama portrays a terminally‑ill doctor forced into the patient role. While the production raises timely questions about euthanasia and NHS pressures, the reviewer finds the writing thin and the pacing sluggish.

Lead

The Guardian’s review of Heartsink critiques Sean Turner’s new stage drama that follows Dr Jeffrey Longford (Aden Gillett) as he transitions from physician to terminal‑cancer patient, exposing tensions between medical authority and patient vulnerability.

The Play’s Premise and Moral Quandaries

Set in a London NHS clinic, the narrative uses “heartsink” patients—those who drain clinicians’ emotional reserves—to explore:

  • the ethical friction surrounding euthanasia,
  • the impact of digitalisation on doctor‑patient interaction,
  • the gender‑neutral redesign of hospital spaces.

Critical Assessment of Writing and Direction

Reviewer Farine Clarke, herself a doctor‑turned‑patient, argues that the script remains “brief and simplistic,” with jokes about artificial intelligence feeling “off‑the‑cuff.” The pacing is described as “slow,” diluting the urgency that similar NHS‑focused plays like Tiger Country achieved.

Performance Highlights

  • Aden Gillett as Dr Longford delivers a pedantic, complaint‑laden performance that borders on Luddite caricature.
  • Megan Marszal as receptionist Suzie provides the only consistent “gallows humour,” though it falls short of genuine wit.
  • Kathy Kiera Clarke (of Derry Girls fame) adds a quirky edge as hypochondriac Cara, briefly hinting at supernatural possibilities.
  • Vikash Bhai offers a gentle counterpoint as a younger GP looking up to Longford.

Heartsink’s Place in Contemporary NHS Drama

While the play raises relevant debates about resource‑strained NHS care, it lacks the “necessary compromises” and “urgency” found in earlier works. The reviewer notes that the dialogue often feels “crude” and the characters “flat,” limiting the audience’s emotional investment.

Future Outlook and Audience Reception

Running at Riverside Studios in London until 10 May 2026, the production may attract theatre‑goers interested in medical ethics, but its mixed critical reception suggests limited longevity beyond the current run.